In the latest fiscal period Q1'27, total operating expenses reached a combined total of $6.14B. This consists of $4.51B in SG&A Expenses and $1.63B in R&D Expenses, representing the highest recorded R&D investment in the analyzed period. From Q2'24 to Q1'27, CRM has exhibited a consistent upward trend in operating costs, with SG&A Expenses remaining the dominant expenditure category. Notable growth occurred in Q4'26, where total expenses spiked significantly to $6.54B before a slight moderation in SG&A during the subsequent quarter. Overall, R&D Expenses have steadily scaled from $1.22B to over $1.6B, reflecting a sustained commitment to product innovation alongside expanding sales and administrative operations.